Novel compounds that are ERK inhibitors

Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also di...

Full description

Saved in:
Bibliographic Details
Main Authors DESAI JAGDISH, SAMATAR AHMED A, WU YIJI, SHIPPS GERALD W.JR, KELLY JOSEPH M, DENG YONGQI, NAN YANG, WANG TONG, PALIWAL SUNIL, SIDDIQUI M. A, DOLL RONALD, SHIH NENG-YANG, WANG JAMES J, HRUZA ALAN W, MADISON VINCENT, DONG YOUHAO, BOGA SOBHANA B, XIAO LI, ZHU HUGH, COOPER ALAN, TSUI HONUNG, SUN ROBERT, CELEBI AZIM A
Format Patent
LanguageEnglish
Published 16.08.2007
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
AbstractList Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1.0.
Author DESAI JAGDISH
SIDDIQUI M. A
SAMATAR AHMED A
COOPER ALAN
SHIPPS GERALD W.JR
BOGA SOBHANA B
SUN ROBERT
KELLY JOSEPH M
WU YIJI
HRUZA ALAN W
DONG YOUHAO
XIAO LI
DENG YONGQI
NAN YANG
MADISON VINCENT
SHIH NENG-YANG
WANG JAMES J
WANG TONG
DOLL RONALD
ZHU HUGH
PALIWAL SUNIL
CELEBI AZIM A
TSUI HONUNG
Author_xml – fullname: DESAI JAGDISH
– fullname: SAMATAR AHMED A
– fullname: WU YIJI
– fullname: SHIPPS GERALD W.JR
– fullname: KELLY JOSEPH M
– fullname: DENG YONGQI
– fullname: NAN YANG
– fullname: WANG TONG
– fullname: PALIWAL SUNIL
– fullname: SIDDIQUI M. A
– fullname: DOLL RONALD
– fullname: SHIH NENG-YANG
– fullname: WANG JAMES J
– fullname: HRUZA ALAN W
– fullname: MADISON VINCENT
– fullname: DONG YOUHAO
– fullname: BOGA SOBHANA B
– fullname: XIAO LI
– fullname: ZHU HUGH
– fullname: COOPER ALAN
– fullname: TSUI HONUNG
– fullname: SUN ROBERT
– fullname: CELEBI AZIM A
BookMark eNrjYmDJy89L5WRQ98svS81RSM7PLcgvzUspVijJSCxRSCxKVXAN8lbIzMvITMosyS8q5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8aHBRgYG5oaWhmYGJo6GxsSpAgAIPCo-
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2007191604A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2007191604A13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:59:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2007191604A13
Notes Application Number: US20060636954
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070816&DB=EPODOC&CC=US&NR=2007191604A1
ParticipantIDs epo_espacenet_US2007191604A1
PublicationCentury 2000
PublicationDate 20070816
PublicationDateYYYYMMDD 2007-08-16
PublicationDate_xml – month: 08
  year: 2007
  text: 20070816
  day: 16
PublicationDecade 2000
PublicationYear 2007
Score 2.6858265
Snippet Disclosed are the ERK inhibitors of formula 1.0: and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Title Novel compounds that are ERK inhibitors
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070816&DB=EPODOC&locale=&CC=US&NR=2007191604A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU2zTDFNTUrWNTG1ABLJSWm6iWZGabrGyeaJqYbGpgZAEdBqCz8zj1ATrwjTCCaGHNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x2bg-6RUHNxsnUN8Hfxd1ZzdrYNDVbzCwLLAbsmZgYmjsC-EiuoIQ06ad81zAm0L6UAuVJxE2RgCwCal1cixMCUmifMwOkMu3tNmIHDFzrlDWRCc1-xCIO6X35Zao4CaBU46DKkYoWSjMQShcSiVAXXIG-FzLyMzKRM0OU5ogzKbq4hzh66QBvj4R6MDw1Gdp6xGAMLsOufKsGgYGxqlgxswJgAA87UxCzNCNjdsDBKTgLt6TA2STQzl2SQwWeSFH5paQYuyEglsB9pJsPAUlJUmioLrGJLkuTAIQMAKzt-PA
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMU2zTDFNTUrWNTG1ABLJSWm6iWZGabrGyeaJqYbGpgZAEdBqCz8zj1ATrwjTCCaGHNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x2bg-6RUHNxsnUN8Hfxd1ZzdrYNDVbzCwLLAbsmZgYmjsC-Eqs5sFMI7iyFOYH2pRQgVypuggxsAUDz8kqEGJhS84QZOJ1hd68JM3D4Qqe8gUxo7isWYVD3yy9LzVEArQIHXYZUrFCSkViikFiUquAa5K2QmZeRmZQJujxHlEHZzTXE2UMXaGM83IPxocHIzjMWY2ABdv1TJRgUjE3NkoENGBNgwJmamKUZAbsbFkbJSaA9HcYmiWbmkgwy-EySwi8tz8DpEeLrE-_j6ectzcAFGbUE9inNZBhYSopKU2WB1W1Jkhw4lAA24YEm
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Novel+compounds+that+are+ERK+inhibitors&rft.inventor=DESAI+JAGDISH&rft.inventor=SAMATAR+AHMED+A&rft.inventor=WU+YIJI&rft.inventor=SHIPPS+GERALD+W.JR&rft.inventor=KELLY+JOSEPH+M&rft.inventor=DENG+YONGQI&rft.inventor=NAN+YANG&rft.inventor=WANG+TONG&rft.inventor=PALIWAL+SUNIL&rft.inventor=SIDDIQUI+M.+A&rft.inventor=DOLL+RONALD&rft.inventor=SHIH+NENG-YANG&rft.inventor=WANG+JAMES+J&rft.inventor=HRUZA+ALAN+W&rft.inventor=MADISON+VINCENT&rft.inventor=DONG+YOUHAO&rft.inventor=BOGA+SOBHANA+B&rft.inventor=XIAO+LI&rft.inventor=ZHU+HUGH&rft.inventor=COOPER+ALAN&rft.inventor=TSUI+HONUNG&rft.inventor=SUN+ROBERT&rft.inventor=CELEBI+AZIM+A&rft.date=2007-08-16&rft.externalDBID=A1&rft.externalDocID=US2007191604A1